Deep insight into the B-cell associated tertiary lymphoid structure and tumor immunotherapy  

作　　者：Jilong Yang Jin Xu Haotian Liu Wanyi Xiao Gengpu Zhang 

机构地区：[1]Department of Bone and Soft Tissue Tumor,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin’s Clinical Research Center for Cancer,Key Laboratory of Molecular Cancer Epidemiology,Tianjin 300060,China [2]Department of Anaesthesiology,Tianjin University Tianjin Hospital,Tianjin 300211,China

出　　处：《Cancer Biology & Medicine》2024年第2期125-131,共7页癌症生物学与医学（英文版）

摘　　要：Bod et al.1 recently published a study in Nature that garnered attention to B cell-associated anti-tumor immunity and immunotherapy of melanoma and other tumors1.As a promising supplemental immunotherapy to mainstream methods that target T and natural killer(NK)cells,B cell-associated anti-tumor immunotherapy is promising。

关 键 词：IMMUNOTHERAPY IMMUNITY 

分 类 号：R730.51[医药卫生—肿瘤]